viewGalan Lithium Ltd

Galan Lithium shares up as first hole at Pata Pila discovers multiple brine aquifers

Pata Pila is part of the Western Basin Projects on the Hombre Muerto salar, a renowned high-grade, low-impurity salt lake in Argentina.

Galan Lithium Ltd - Galan Lithium shares up as first hole at Pata Pila hits brine
Initial samples from the hole have been sent to the lab

Galan Lithium Ltd (ASX:GLN) has intersected several heavy brine-bearing aquifers in its maiden drill hole at Pata Pila.

Drill hole PP-19-01 is at a depth of 647 metres and has intersected three major brine horizons all containing heavy brines as per the results table below.

Minimal sampling has been undertaken to date with more to occur once the hole has been completed.

The initial samples have been sent to the laboratory for analysis with results due shortly.

Discovery of multiple aquifers beyond expectations

Galan’s managing director Juan Pablo Vargas de la Vega said: “The discovery of heavy brines not only in the Livent production aquifer but also from two new previously unknown aquifers at Pata Pila is beyond our expectations.

“We are very excited by the potential of Pata Pila to host a significant lithium brine resource and are confident that Galan has the potential to increase its lithium resource inventory beyond the maiden Candelas resource estimate due this month.

“Following the maiden resource at Candelas, Galan will look to commence a pre-feasibility study (PFS) into the potential development of the project.”

Quick facts: Galan Lithium Ltd

Price: 0.48 AUD

Market: ASX
Market Cap: $115.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinetic results confirms it can begin second...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 17 hours ago

2 min read